NCT07713537 Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
| NCT ID | NCT07713537 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute |
| Condition | Atrial Fibrillation (AF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2025-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). Evidence-based scale is necessary to assess ischemic stroke risk in atrial fibrillation (AF) patients.
Eligibility Criteria
Inclusion Criteria: * Patient over 18 years of age * History of AD * Currently on DOACs. * Capacity to understand the study procedures and provide informed consent. Exclusion Criteria: * Patient with valvular AF (mitral stenosis) or mechanical valve prostheses. * Unable to complete a follow-up period of at least 3 months from enrollment.
Frequently Asked Questions
Who can join the NCT07713537 clinical trial?
This trial is open to participants of all sexes, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07713537 currently recruiting?
Yes, NCT07713537 is actively recruiting participants. Visit ClinicalTrials.gov or contact Hospital Universitari Vall d'Hebron Research Institute to inquire about joining.
Where is the NCT07713537 trial being conducted?
This trial is being conducted at Barcelona, Spain, Barcelona, Spain.
Who is sponsoring the NCT07713537 clinical trial?
NCT07713537 is sponsored by Hospital Universitari Vall d'Hebron Research Institute. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.